Neo Ivy Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-514
| Closed | -$22K | – | 459 |
|
|
2022
Q1 | $22K | Buy |
+514
| New | +$22K | 0.02% | 423 |
|
|
2021
Q4 | – | Sell |
-117
| Closed | -$9K | – | 479 |
|
|
2021
Q3 | $9K | Buy |
+117
| New | +$9K | 0.01% | 417 |
|
|
2021
Q1 | – | Sell |
-403
| Closed | -$36K | – | 508 |
|
|
2020
Q4 | $36K | Buy |
403
+342
| +561% | +$30.6K | 0.04% | 332 |
|
|
2020
Q3 | $6K | Sell |
61
-56
| -48% | -$5.51K | 0.01% | 435 |
|
|
2020
Q2 | $9K | Sell |
117
-442
| -79% | -$34K | 0.01% | 417 |
|
|
2020
Q1 | $32K | Buy |
+559
| New | +$32K | 0.05% | 348 |
|
|
2019
Q2 | – | Sell |
-10,683
| Closed | -$539K | – | 306 |
|
|
2019
Q1 | $539K | Buy |
10,683
+4,048
| +61% | +$204K | 0.31% | 147 |
|
|
2018
Q4 | $393K | Buy |
+6,635
| New | +$393K | 0.31% | 144 |
|